T1	Modifier 63 94	locoregional oral squamous cell
E1	Modifier:T1 Modifies:T53
T2	Condition 95 104	carcinoma
E2	Condition:T2 Name:T53 Temporality:E53
T3	Condition 106 110	OSCC
E3	Condition:T3 Name:T54
T4	Negation 112 119	without
E4	Negation:T4 Negates:E6
T5	Modifier 132 139	distant
E5	Modifier:T5 Modifies:T55
T6	Condition 140 150	metastases
E6	Condition:T6 Name:T55
T7	Condition 152 156	OSCC
E7	Condition:T7 Name:T79
T8	Modifier 170 193	subsites of oral tongue
E8	Modifier:T8 Modifies:T79
T9	Modifier 195 209	floor of mouth
E9	Modifier:T9 Modifies:T79
T10	Modifier 211 218	gingiva
E10	Modifier:T10 Modifies:T79
T11	Modifier 220 238	retromolar trigone
E11	Modifier:T11 Modifies:T79
T12	Or 239 242	and
E12	Or:T12 Arg:E11 Arg2:E13
T13	Modifier 243 256	buccal mucosa
E13	Modifier:T13 Modifies:T79
T14	Or 257 259	OR
E14	Or:T14 Arg:E7 Arg2:E15
T15	Modifier 260 269	Recurrent
E15	Modifier:T15 Modifies:T58
T16	Or 270 272	or
E16	Or:T16 Arg:E15 Arg2:E17
T17	Modifier 273 283	persistent
E17	Modifier:T17 Modifies:T58
T18	Modifier 306 318	locoregional
E18	Modifier:T18 Modifies:T58
T19	Condition 319 323	OSCC
E19	Condition:T19 Name:T58
T20	Eq-Comparison 333 342	initially
E20	Eq-Comparison:T20 Temporal-Recency:T56
T21	Procedure 343 350	treated
E21	Procedure:T21 Temporality:E20
T22	Procedure 356 363	surgery
E22	Procedure:T22 Name:T59
T23	Assertion 384 396	eligible for
E23	Assertion:T23 Asserted:E24
A1	Assertion-Type-Value E23 hypothetical
T24	Procedure 397 415	surgical resection
E24	Procedure:T24 Name:T60
T25	Eq-Comparison 421 442	greater than 18 years
E25	Eq-Comparison:T25 Operator:T61 Value:T62 Temporal-Unit:T63
T26	Age 446 449	age
E26	Age:T26 Eq-Comparison:E25
T27	Eq-Comparison 475 480	prior
E27	Eq-Comparison:T27 Temporal-Period:T64
T28	Procedure 481 494	immunotherapy
E28	Procedure:T28 Name:T65
T29	Or 495 497	or
E29	Or:T29 Arg:E28 Arg2:E30
T30	Procedure 498 507	treatment
E30	Procedure:T30 
T31	Other 513 520	another
E31	Other:T31 Is-Other:E32
T32	Drug 521 536	anti PD-1 agent
E32	Drug:T32 Name:T66
T33	Drug 545 554	nivolumab
E33	Drug:T33 Name:T67
T34	Eq-Comparison 560 565	prior
E34	Eq-Comparison:T34 Temporal-Period:T68
T35	Procedure 566 578	chemotherapy
E35	Procedure:T35 Name:T69 Temporality:E34
T36	Drug 589 598	cetuximab
E36	Drug:T36 Name:T70
T37	Or 599 601	or
E37	Or:T37 Arg:E36 Arg2:E38
T38	Procedure 602 619	radiation therapy
E38	Procedure:T38 Name:T71
T39	Condition 637 649	malignancies
E39	Condition:T39 Name:T81
T40	Exception 650 656	except
E40	Exception:T40 From:E39 Except:E42 Except2:E45
T41	Modifier 657 680	cutaneous squamous cell
E41	Modifier:T41 Modifies:T72
T42	Condition 681 690	carcinoma
E42	Condition:T42 Name:T72
T43	Or 691 693	or
E43	Or:T43 Arg:E42 Arg2:E45
T44	Modifier 694 704	basal cell
E44	Modifier:T44 Modifies:T73
T45	Condition 705 714	carcinoma
E45	Condition:T45 Name:T73
T46	Modifier 720 740	unresectable primary
E46	Modifier:T46 Modifies:T74
T47	Condition 741 746	tumor
E47	Condition:T47 Name:T74
T48	Or 747 749	or
E48	Or:T48 Arg:E47 Arg2:E49
T49	Condition 750 766	regional disease
E49	Condition:T49 Name:T75
T50	Or 767 769	or
E50	Or:T50 Arg:E49 Arg2:E52
T51	Modifier 770 777	distant
E51	Modifier:T51 Modifies:T76
T52	Condition 778 788	metastases
E52	Condition:T52 Name:T76
T53	Condition-Name 95 104	carcinoma
T54	Condition-Name 106 110	OSCC
T55	Condition-Name 140 150	metastases
T58	Condition-Name 319 323	OSCC
T59	Procedure-Name 356 363	surgery
T60	Procedure-Name 397 415	surgical resection
T61	Eq-Operator 421 433	greater than
A2	Eq-Operator-Value T61 GT
T62	Eq-Value 434 436	18
T63	Eq-Temporal-Unit 437 442	years
A3	Eq-Temporal-Unit-Value T63 year
T64	Eq-Temporal-Period 475 480	prior
A4	Eq-Temporal-Period-Value T64 past
T65	Procedure-Name 481 494	immunotherapy
T66	Drug-Name 521 536	anti PD-1 agent
T67	Drug-Name 545 554	nivolumab
T68	Eq-Temporal-Period 560 565	prior
A5	Eq-Temporal-Period-Value T68 past
T69	Procedure-Name 566 578	chemotherapy
T70	Drug-Name 589 598	cetuximab
T71	Procedure-Name 602 619	radiation therapy
T72	Condition-Name 681 690	carcinoma
T73	Condition-Name 705 714	carcinoma
T74	Condition-Name 741 746	tumor
T75	Condition-Name 750 766	regional disease
T76	Condition-Name 778 788	metastases
T77	Eq-Comparison 25 30	Newly
E53	Eq-Comparison:T77 Temporal-Recency:T78
T78	Eq-Temporal-Recency 25 30	Newly
A6	Eq-Temporal-Recency-Value T78 first-time
R1	Example-Of Arg1:E3 Arg2:E2	
T79	Condition-Name 152 156	OSCC
T56	Eq-Temporal-Recency 333 342	initially
A7	Eq-Temporal-Recency-Value T56 first-time
R2	Treatment-For Arg1:E21 Arg2:E19	
R3	Using Arg1:E21 Arg2:E22	
R4	Equivalent-To Arg1:E28 Arg2:E27	
R5	Using Arg1:E30 Arg2:E32	
T57	Exception 537 544	besides
E54	Exception:T57 From:E32 Except:E33
R6	Example-Of Arg1:E36 Arg2:E35	
R7	Example-Of Arg1:E38 Arg2:E35	
T80	Modifier 625 636	concomitant
E55	Modifier:T80 Modifies:T81
T81	Condition-Name 637 649	malignancies
